Circulating tumor cells, release

The physiological function of heparin is not completely understood. It is found only in trace amounts in normal circulating blood. It exerts an antihpemic effect by releasing lipoprotein lipase from endothehal cells heparinlike proteoglycans produced by endothelial cells have anticoagulant activity. Heparin decreases platelet and inflammatory cell adhesiveness to endothelial cells, reduces the release of platelet-derived growth factor, inhibits tumor cell metastasis, and exerts an antiproliferative effect on several types of smooth muscle. 

A large number of tumor blood vessels increases the opportunity of the tumor cells to enter the circulation. In fact, the newly formed capillaries usually have a fragmented basement membrane, facilitating easier invasion. In the prevascular phase, with little or no angiogenic activity, the tumor is unable to expand beyond a few cubic millimeters, but once angiogenic factors are released in sufficient number, the onset of angiogenic activity stimulates rapid expansion of the tumor. 

Quantitation of tumor cell adhesion on EC monolayers is usually done by adding labeled tumor cells for a short period of time (from 0.5 to 4 h), since this type of interaction during the process of tumor metastasis in vivo is supposed to occur soon after the release of malignant cells into the circulation. We will describe below different methods for labeling and detection of tumor cells to be used in the adhesion assay. 

Fig. 2 Schematic demonstration of different routes of drug release and cellular uptake. After a drug delivery system is administered, different events occur. Route a drug A is released during circulation and is taken up by both normal cells and tumor cells. Route b drug B is transported to the tumor interstitum and released extracellularly at the tumor site, and mainly taken up by tumor cells. Route c drug C is endocytosed with its carrier and released in the endosomes or lysosomes.

In their host, tumor cells and lymphocytes (immune T cell NK cells) encounter each other, and both subjects of observation emit exosomes. The exosomes are engulfed by various host cells. Even in the case of an incipient and localized tumor, the entire host is made aware that a malignantly transformed cell colony is on board. It is under extensive investigation what biological effects exosomes may convey. With considerable oversimplification, it appears that exosomes of tumor cell-derivation are more immunosuppressive than immunostimulatory. Whereas exosomes derived from reactive DCs and immune T cells convey immunostimulatory effects. Tumor cells communicate to re-assert their presence by releasing microvesicles in the host s blood and lymph circulation [1960-1964]. 

---